174 related articles for article (PubMed ID: 30986029)
1. Codelivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth.
Cheng CS; Liu TP; Chien FC; Mou CY; Wu SH; Chen YP
ACS Appl Mater Interfaces; 2019 May; 11(17):15322-15331. PubMed ID: 30986029
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and anti-cancer activity in vitro of curcumin loaded mesoporous silica nanoparticle].
He LL; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(21):4189-93. PubMed ID: 27071254
[TBL] [Abstract][Full Text] [Related]
4. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase.
Chen YP; Chen CT; Hung Y; Chou CM; Liu TP; Liang MR; Chen CT; Mou CY
J Am Chem Soc; 2013 Jan; 135(4):1516-23. PubMed ID: 23289802
[TBL] [Abstract][Full Text] [Related]
5. Approach To Deliver Two Antioxidant Enzymes with Mesoporous Silica Nanoparticles into Cells.
Lin YH; Chen YP; Liu TP; Chien FC; Chou CM; Chen CT; Mou CY
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17944-54. PubMed ID: 27353012
[TBL] [Abstract][Full Text] [Related]
6. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
[TBL] [Abstract][Full Text] [Related]
7. Delivery of curcumin by fucoidan-coated mesoporous silica nanoparticles: Fabrication, characterization, and in vitro release performance.
Zhang X; Zhu Y; Fan L; Ling J; Yang LY; Wang N; Ouyang XK
Int J Biol Macromol; 2022 Jun; 211():368-379. PubMed ID: 35577185
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
9. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Characterization, and Evaluation of the Anticancer Effect of Mesoporous Silica Nanoparticles Containing Rutin and Curcumin.
Dizaj SM; Kouhsoltani M; Pourreza K; Sharifi S; Abdolahinia ED
Pharm Nanotechnol; 2024; 12(3):269-275. PubMed ID: 37594097
[TBL] [Abstract][Full Text] [Related]
11. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
12. Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy.
Li T; Shen X; Geng Y; Chen Z; Li L; Li S; Yang H; Wu C; Zeng H; Liu Y
ACS Appl Mater Interfaces; 2016 Jun; 8(22):13748-58. PubMed ID: 27191965
[TBL] [Abstract][Full Text] [Related]
13. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement.
Hartono SB; Hadisoewignyo L; Yang Y; Meka AK; Antaresti ; Yu C
Nanotechnology; 2016 Dec; 27(50):505605. PubMed ID: 27875331
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells.
Bollu VS; Barui AK; Mondal SK; Prashar S; Fajardo M; Briones D; Rodríguez-Diéguez A; Patra CR; Gómez-Ruiz S
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():393-410. PubMed ID: 27040234
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency.
Ghosh S; Dutta S; Sarkar A; Kundu M; Sil PC
Colloids Surf B Biointerfaces; 2021 Jan; 197():111404. PubMed ID: 33142257
[TBL] [Abstract][Full Text] [Related]
16. Charge-Selective Delivery of Proteins Using Mesoporous Silica Nanoparticles Fused with Lipid Bilayers.
Shi H; Liu S; Cheng J; Yuan S; Yang Y; Fang T; Cao K; Wei K; Zhang Q; Liu Y
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3645-3653. PubMed ID: 30609348
[TBL] [Abstract][Full Text] [Related]
17. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.
Pan L; He Q; Liu J; Chen Y; Ma M; Zhang L; Shi J
J Am Chem Soc; 2012 Apr; 134(13):5722-5. PubMed ID: 22420312
[TBL] [Abstract][Full Text] [Related]
18. Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles.
Wang D; Yu D; Liu X; Wang Q; Chen X; Hu X; Wang Q; Jin C; Wen L; Zhang L
Technol Cancer Res Treat; 2020; 19():1533033820962114. PubMed ID: 33267716
[TBL] [Abstract][Full Text] [Related]
19. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
